Cancer Diagnosis at the Crossroads: Precision Medicine Driving Change 2014 presents products and services in categories such as:
- Successful Implementation of Precision Medicine in Clinical Cancer Care: The UW Experience
- Integrating Laboratory and Clinical Informatics for Next-Generation Sequencing Assays
- Integrative Genomic Analysis of Gastric Cancer
- Novel Technologies Enabling Exploratory Biomarker Analysis in the Clinic
- Next-Generation Patient-Derived Prostate Cancer Xenograft Models
- Development of New Therapeutic Agents Targeting Key Cancer Stem Cell Pathways
- Molecular Characterization of Patient-Derived Human Pancreatic Tumor Xenograft Models for Preclinical and Translational Development of Cancer Therapeutics
- Understanding Cancer Stem Cells in Human Melanoma Using a Patient-Derived Tumor Xenograft Model
Cancer Diagnosis at the Crossroads: Precision Medicine Driving Change 2014 brings together international oncology experts in the fields of:
- PDX models
- Tumor biospecimen research
- Pharmacogenomics>
- Molecular diagnostics/prognostics
